{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:16:04Z","timestamp":1757614564656,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"DOI":"10.7759\/cureus.91643","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:14:17Z","timestamp":1757060057000},"source":"Crossref","is-referenced-by-count":0,"title":["KRAS and NRAS Mutations in Relation to Microsatellite Status in Colorectal Cancer: A Single-Center Study From Romania"],"prefix":"10.7759","author":[{"given":"Ramona","family":"Abrudan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Abrudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreea","family":"Camarasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Camarasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Burta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"Pop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"unstructured":"Colorectal cancer. (2023). Accessed. January 13, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer.","key":"ref1"},{"unstructured":"COPAC. cancerul colorectal - peste 13% din totalul cancerelor \u00een Rom\u00e2nia. (2024). Accessed: January 13, 2024: https:\/\/cancer-plan.ro\/copac-cancerul-colorectal-peste-13-din-totalul-cancerelor-in-romania\/.","key":"ref2"},{"unstructured":"Colon Cancer. (2018). Accessed. January 13, 2025: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&amp;id=1428.","key":"ref3"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes A","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, et al.. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023, 34:10-32. 10.1016\/j.annonc.2022.10.003","journal-title":"Ann Oncol"},{"unstructured":"Colorectum. (2024). Accessed. January 13, 2025: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/cancers\/41-colorectum-fact-sheet.pdf.","key":"ref5"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030979","article-title":"KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania","volume":"101","author":"Brinzan CS","year":"2022","unstructured":"Brinzan CS, Aschie M, Cozaru GC, Deacu M, Dumitru E, Burlacu I, Mitroi A. KRAS, NRAS, BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern Romania. Medicine (Baltimore). 2022, 101:e30979. 10.1097\/MD.0000000000030979","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s G","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, et al.. Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020, 31:1291-305. 10.1016\/j.annonc.2020.06.022","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081530","article-title":"Colorectal cancer: epidemiology, risk factors, and prevention","volume":"16","author":"Roshandel G","year":"2024","unstructured":"Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024, 16:1530. 10.3390\/cancers16081530","journal-title":"Cancers (Basel)"},{"unstructured":"Colorectal cancer statistics. (2024). Accessed. January 13, 2025: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/colorectal-cancer-statistics\/.","key":"ref9"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill JA","year":"1990","unstructured":"Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990, 113:779-88. 10.7326\/0003-4819-113-10-779","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1442217","article-title":"Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype","volume":"18","author":"Yang SY","year":"2018","unstructured":"Yang SY, Cho MS, Kim NK. Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype. Expert Rev Anticancer Ther. 2018, 18:351-8. 10.1080\/14737140.2018.1442217","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47824","article-title":"A rare case of an occult primary tumor with a profile of colon cancer and synchronous metastasis in the lung, liver, bone, and cerebellum: a case report and literature review","volume":"15","author":"Abrudan R","year":"2023","unstructured":"Abrudan R, Abrudan L, Pop O, Zaha DC. A rare case of an occult primary tumor with a profile of colon cancer and synchronous metastasis in the lung, liver, bone, and cerebellum: a case report and literature review. Cureus. 2023, 15:e47824. 10.7759\/cureus.47824","journal-title":"Cureus"},{"key":"ref13","article-title":"Anatomia Omului. Vol II. Splanhnologia. 12th ed","author":"Victor P","year":"1976","unstructured":"Victor P. Anatomia Omului. Vol II. Splanhnologia. 12th ed. ALL, Bucharest; 1976."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis","volume":"13","author":"Sawicki T","year":"2021","unstructured":"Sawicki T, Ruszkowska M, Danielewicz A, Nied\u017awiedzka E, Ar\u0142ukowicz T, Przyby\u0142owicz KE. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel). 2021, 13:2025. 10.3390\/cancers13092025","journal-title":"Cancers (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix F","year":"2010","unstructured":"Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum. 2010, 53:57-64. 10.1007\/DCR.0b013e3181c703a4","journal-title":"Dis Colon Rectum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11888-018-0411-z","article-title":"Molecular variances between right- and left-sided colon cancers","volume":"14","author":"Puccini A","year":"2018","unstructured":"Puccini A, Marshall JL, Salem ME. Molecular variances between right- and left-sided colon cancers. Curr Colorectal Cancer Rep. 2018, 14:152-8. 10.1007\/s11888-018-0411-z","journal-title":"Curr Colorectal Cancer Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2019.17770","article-title":"Fall of another myth for colon cancer: Duration of symptoms does not differ between right- or left-sided colon cancers","volume":"30","author":"\u00d6zt\u00fcrk E","year":"2019","unstructured":"\u00d6zt\u00fcrk E, Kuzu MA, \u00d6ztuna D, et al.. Fall of another myth for colon cancer: Duration of symptoms does not differ between right- or left-sided colon cancers. Turk J Gastroenterol. 2019, 30:686-94. 10.5152\/tjg.2019.17770","journal-title":"Turk J Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45100491","article-title":"Molecular pattern and clinical implications of KRAS\/NRAS and BRAF mutations in colorectal cancer","volume":"45","author":"G\u00f6kmen \u0130","year":"2023","unstructured":"G\u00f6kmen \u0130, Ta\u015ftekin E, Demir N, et al.. Molecular pattern and clinical implications of KRAS\/NRAS and BRAF mutations in colorectal cancer. Curr Issues Mol Biol. 2023, 45:7803-12. 10.3390\/cimb45100491","journal-title":"Curr Issues Mol Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-019-0028-z","article-title":"Clinicopathological features of Egyptian colorectal cancer patients regarding somatic genetic mutations especially in KRAS gene and microsatellite instability status: a pilot study","volume":"20","author":"Kassem NM","year":"2019","unstructured":"Kassem NM, Emera G, Kassem HA, et al.. Clinicopathological features of Egyptian colorectal cancer patients regarding somatic genetic mutations especially in KRAS gene and microsatellite instability status: a pilot study. Egypt J Med Hum Genet. 2019, 20:20. 10.1186\/s43042-019-0028-z","journal-title":"Egypt J Med Hum Genet"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S428580","article-title":"KRAS\/NRAS mutations associated with distant metastasis and BRAF\/PIK3CA mutations associated with poor tumor differentiation in colorectal cancer","volume":"16","author":"Zeng J","year":"2023","unstructured":"Zeng J, Fan W, Li J, Wu G, Wu H. KRAS\/NRAS mutations associated with distant metastasis and BRAF\/PIK3CA mutations associated with poor tumor differentiation in colorectal cancer. Int J Gen Med. 2023, 16:4109-20. 10.2147\/IJGM.S428580","journal-title":"Int J Gen Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24444","article-title":"Mutation patterns and prognostic analysis of BRAF\/KRAS\/PIK3CA in colorectal cancer","volume":"36","author":"Wang C","year":"2022","unstructured":"Wang C, Pan D. Mutation patterns and prognostic analysis of BRAF\/KRAS\/PIK3CA in colorectal cancer. J Clin Lab Anal. 2022, 36:e24444. 10.1002\/jcla.24444","journal-title":"J Clin Lab Anal"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23675","article-title":"The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer","volume":"110","author":"Lin CC","year":"2014","unstructured":"Lin CC, Lin JK, Lin TC, et al.. The prognostic role of microsatellite instability, codon-specific KRAS, and BRAF mutations in colon cancer. J Surg Oncol. 2014, 110:451-7. 10.1002\/jso.23675","journal-title":"J Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041022","article-title":"Challenges and therapeutic opportunities in the dMMR\/MSI-H colorectal cancer landscape","volume":"15","author":"Mulet-Margalef N","year":"2023","unstructured":"Mulet-Margalef N, Linares J, Badia-Ramentol J, Jimeno M, Sanz Monte C, Manzano Mozo JL, Calon A. Challenges and therapeutic opportunities in the dMMR\/MSI-H colorectal cancer landscape. Cancers (Basel). 2023, 15:1022. 10.3390\/cancers15041022","journal-title":"Cancers (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9611","article-title":"Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer","volume":"17","author":"Niu W","year":"2019","unstructured":"Niu W, Wang G, Feng J, Li Z, Li C, Shan B. Correlation between microsatellite instability and RAS gene mutation and stage III colorectal cancer. Oncol Lett. 2019, 17:332-8. 10.3892\/ol.2018.9611","journal-title":"Oncol Lett"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2013.012","article-title":"Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy","volume":"4","author":"Demes M","year":"2013","unstructured":"Demes M, Scheil-Bertram S, Bartsch H, Fisseler-Eckhoff A. Signature of microsatellite instability, KRAS and BRAF gene mutations in German patients with locally advanced rectal adenocarcinoma before and after neoadjuvant 5-FU radiochemotherapy. J Gastrointest Oncol. 2013, 4:182-92. 10.3978\/j.issn.2078-6891.2013.012","journal-title":"J Gastrointest Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00640-7","article-title":"Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer","volume":"12","author":"Fan WX","year":"2024","unstructured":"Fan WX, Su F, Zhang Y, et al.. Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer. Biomark Res. 2024, 12:89. 10.1186\/s40364-024-00640-7","journal-title":"Biomark Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30040279","article-title":"Developments in checkpoint inhibitor therapy for the management of deficient mismatch repair (dMMR) rectal cancer","volume":"30","author":"Su A","year":"2023","unstructured":"Su A, Pedraza R, Kennecke H. Developments in checkpoint inhibitor therapy for the management of deficient mismatch repair (dMMR) rectal cancer. Curr Oncol. 2023, 30:3672-83. 10.3390\/curroncol30040279","journal-title":"Curr Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.9807","article-title":"Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Sepulveda AR","year":"2017","unstructured":"Sepulveda AR, Hamilton SR, Allegra CJ, et al.. Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017, 35:1453-86. 10.1200\/JCO.2016.71.9807","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bdq.2016.05.001","article-title":"Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)","volume":"8","author":"Cree IA","year":"2016","unstructured":"Cree IA. Diagnostic RAS mutation analysis by polymerase chain reaction (PCR). Biomol Detect Quantif. 2016, 8:29-32. 10.1016\/j.bdq.2016.05.001","journal-title":"Biomol Detect Quantif"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2017.10.026","article-title":"Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer","volume":"489","author":"Iida T","year":"2019","unstructured":"Iida T, Mizuno Y, Kaizaki Y. Real-time PCR-based method for the rapid detection of extended RAS mutations using bridged nucleic acids in colorectal cancer. Clin Chim Acta. 2019, 489:164-8. 10.1016\/j.cca.2017.10.026","journal-title":"Clin Chim Acta"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4191","article-title":"Classification and characterization of microsatellite instability across 18 cancer types","volume":"22","author":"Hause RJ","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016, 22:1342-50. 10.1038\/nm.4191","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini C","year":"2019","unstructured":"Luchini C, Bibeau F, Ligtenberg MJ, et al.. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019, 30:1232-43. 10.1093\/annonc\/mdz116","journal-title":"Ann Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0124-3","article-title":"Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma","volume":"31","author":"Bisht S","year":"2014","unstructured":"Bisht S, Ahmad F, Sawaimoon S, Bhatia S, Das BR. Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma. Med Oncol. 2014, 31:124. 10.1007\/s12032-014-0124-3","journal-title":"Med Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-024-01571-5","article-title":"Concordance between immunohistochemistry and MSI analysis for detection of MMR\/MSI status in colorectal cancer patients","volume":"19","author":"Faizee MI","year":"2024","unstructured":"Faizee MI, Talib NA, Hamdan AH, et al.. Concordance between immunohistochemistry and MSI analysis for detection of MMR\/MSI status in colorectal cancer patients. Diagn Pathol. 2024, 19:155. 10.1186\/s13000-024-01571-5","journal-title":"Diagn Pathol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033115","article-title":"KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China","volume":"102","author":"Lian SY","year":"2023","unstructured":"Lian SY, Tan LX, Liu XZ, et al.. KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China. Medicine (Baltimore). 2023, 102:e33115. 10.1097\/MD.0000000000033115","journal-title":"Medicine (Baltimore)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005649","article-title":"Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer","volume":"95","author":"Hu J","year":"2016","unstructured":"Hu J, Yan WY, Xie L, et al.. Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer. Medicine (Baltimore). 2016, 95:e5649. 10.1097\/MD.0000000000005649","journal-title":"Medicine (Baltimore)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12962-022-00339-2","article-title":"Treatment pathways and associated costs of metastatic colorectal cancer in Greece","volume":"20","author":"Sougklakos I","year":"2022","unstructured":"Sougklakos I, Athanasiadis E, Boukovinas I, et al.. Treatment pathways and associated costs of metastatic colorectal cancer in Greece. Cost Eff Resour Alloc. 2022, 20:7. 10.1186\/s12962-022-00339-2","journal-title":"Cost Eff Resour Alloc"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-20-487","article-title":"Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis","volume":"11","author":"Zhang C","year":"2020","unstructured":"Zhang C, Ding H, Sun S, Luan Z, Liu G, Li Z. Incidence and detection of high microsatellite instability in colorectal cancer in a Chinese population: a meta-analysis. J Gastrointest Oncol. 2020, 11:1155-63. 10.21037\/jgo-20-487","journal-title":"J Gastrointest Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal A","year":"2024","unstructured":"Singhal A, Li BT, O'Reilly EM. Targeting KRAS in cancer. Nat Med. 2024, 30:969-83. 10.1038\/s41591-024-02903-0","journal-title":"Nat Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-024-01064-0","article-title":"Exploring the relationship between KRAS, NRAS, and BRAF mutations and clinical characteristics in Iranian colorectal cancer patients","volume":"55","author":"Mosaferi Z","year":"2024","unstructured":"Mosaferi Z, Pirestani M, Arefian E, et al.. Exploring the relationship between KRAS, NRAS, and BRAF mutations and clinical characteristics in Iranian colorectal cancer patients. J Gastrointest Cancer. 2024, 55:1134-43. 10.1007\/s12029-024-01064-0","journal-title":"J Gastrointest Cancer"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S133203","article-title":"Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation","volume":"10","author":"Pang XL","year":"2017","unstructured":"Pang XL, Li QX, Ma ZP, et al.. Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation. Onco Targets Ther. 2017, 10:2645-54. 10.2147\/OTT.S133203","journal-title":"Onco Targets Ther"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248522","article-title":"Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: a first report","volume":"16","author":"El Agy F","year":"2021","unstructured":"El Agy F, El Bardai S, El Otmani I, et al.. Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: a first report. PLoS One. 2021, 16:e0248522. 10.1371\/journal.pone.0248522","journal-title":"PLoS One"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1276-z","article-title":"A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer","volume":"15","author":"Kawazoe A","year":"2015","unstructured":"Kawazoe A, Shitara K, Fukuoka S, et al.. A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer. BMC Cancer. 2015, 15:258. 10.1186\/s12885-015-1276-z","journal-title":"BMC Cancer"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/srep18678","article-title":"Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases","volume":"5","author":"Zhang J","year":"2015","unstructured":"Zhang J, Zheng J, Yang Y, et al.. Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep. 2015, 5:18678. 10.1038\/srep18678","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004652","article-title":"KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study","volume":"4","author":"Negru S","year":"2014","unstructured":"Negru S, Papadopoulou E, Apessos A, et al.. KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study. BMJ Open. 2014, 4:e004652. 10.1136\/bmjopen-2013-004652","journal-title":"BMJ Open"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14101001","article-title":"Unraveling the interplay of KRAS, NRAS, BRAF, and micro-satellite instability in non-metastatic colon cancer: a systematic review","volume":"14","author":"Orlandi E","year":"2024","unstructured":"Orlandi E, Giuffrida M, Trubini S, et al.. Unraveling the interplay of KRAS, NRAS, BRAF, and micro-satellite instability in non-metastatic colon cancer: a systematic review. Diagnostics (Basel). 2024, 14:1001. 10.3390\/diagnostics14101001","journal-title":"Diagnostics (Basel)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317692265","article-title":"Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: next-generation sequencing-based cohort study","volume":"39","author":"Jauhri M","year":"2017","unstructured":"Jauhri M, Bhatnagar A, Gupta S, Bp M, Minhas S, Shokeen Y, Aggarwal S. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: next-generation sequencing-based cohort study. Tumour Biol. 2017, 39:1010428317692265. 10.1177\/1010428317692265","journal-title":"Tumour Biol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037693","article-title":"Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer","volume":"103","author":"Wang W","year":"2024","unstructured":"Wang W, Wang R, Han X, Zhang W, Zhu L, Gu Y. Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer. Medicine (Baltimore). 2024, 103:e37693. 10.1097\/MD.0000000000037693","journal-title":"Medicine (Baltimore)"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djab190","article-title":"KRAS and BRAF mutations in stage II and III colon cancer: a systematic review and meta-analysis","volume":"114","author":"Formica V","year":"2022","unstructured":"Formica V, Sera F, Cremolini C, Riondino S, Morelli C, Arkenau HT, Roselli M. KRAS and BRAF mutations in stage II and III colon cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2022, 114:517-27. 10.1093\/jnci\/djab190","journal-title":"J Natl Cancer Inst"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8945","article-title":"A meta-analysis of MSI frequency and race in colorectal cancer","volume":"7","author":"Ashktorab H","year":"2016","unstructured":"Ashktorab H, Ahuja S, Kannan L, et al.. A meta-analysis of MSI frequency and race in colorectal cancer. Oncotarget. 2016, 7:34546-57. 10.18632\/oncotarget.8945","journal-title":"Oncotarget"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29855","article-title":"Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers","volume":"138","author":"de Cuba EM","year":"2016","unstructured":"de Cuba EM, Snaebjornsson P, Heideman DA, et al.. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers. Int J Cancer. 2016, 138:1139-45. 10.1002\/ijc.29855","journal-title":"Int J Cancer"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7619","article-title":"Microsatellite instability and KRAS mutation in stage IV colorectal cancer: prevalence, geographic discrepancies, and outcomes from the National Cancer Database","volume":"19","author":"Uhlig J","year":"2021","unstructured":"Uhlig J, Cecchini M, Sheth A, Stein S, Lacy J, Kim HS. Microsatellite instability and KRAS mutation in stage IV colorectal cancer: prevalence, geographic discrepancies, and outcomes from the National Cancer Database. J Natl Compr Canc Netw. 2021, 19:307-18. 10.6004\/jnccn.2020.7619","journal-title":"J Natl Compr Canc Netw"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128202","article-title":"Distinct clinicopathological patterns of mismatch repair status in colorectal cancer stratified by KRAS mutations","volume":"10","author":"Li W","year":"2015","unstructured":"Li W, Zhi W, Zou S, et al.. Distinct clinicopathological patterns of mismatch repair status in colorectal cancer stratified by KRAS mutations. PLoS One. 2015, 10:e0128202. 10.1371\/journal.pone.0128202","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398597-kras-and-nras-mutations-in-relation-to-microsatellite-status-in-colorectal-cancer-a-single-center-study-from-romania","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:14:25Z","timestamp":1757060065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398597-kras-and-nras-mutations-in-relation-to-microsatellite-status-in-colorectal-cancer-a-single-center-study-from-romania"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.91643","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}